Cornelia de Moor

Dr. Cornelia de Moor

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1999 in Molecular Cell
Verified
Journal Article
Closed access
BSBarbara Stebbins-Boaz
Barbara Stebbins-Boaz
QCQuiping Cao
Quiping Cao
CMCornelia de Moor
Cornelia de Moor
RMRaul Mendez
Raul Mendez
JRJoel D Richter
Joel D Richter

1 February 2005 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
CMCornelia de Moor
Cornelia de Moor
HMHedda Meijer
Hedda Meijer
SLSarah Lissenden
Sarah Lissenden

1 April 2008 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Open access
HRHelois E. Radford
Helois E. Radford
HMHedda A. Meijer
Hedda A. Meijer
CMCornelia de Moor
Cornelia de Moor
Elongation of the poly(A) tails of specific mRNAs in the cytoplasm is a crucial regulatory step in oogenesis and early development of many animal species. The best studied example is the regulation of translation by cytoplasmic polyadenylation elements (CPEs) in the 3' untranslated region of mRNAs involved in Xenopus oocyte maturation. In this review we discuss the mechanism of translational control by the CPE binding protein (CPEB) in Xenopus oocytes as follows: 1. The cytoplasmic polyadenylation machinery such as CPEB, the subunits of cleavage and polyadenylation specificity factor (CPSF), symplekin, Gld-2 and poly(A) polymerase (PAP). 2. The signal transduction that leads to the activation of CPE-mediated polyadenylation during oocyte maturation, including the potential roles of kinases such as MAPK, Aurora A, CamKII, cdk1/Ringo and cdk1/cyclin B. 3. The role of deadenylation and translational repression, including the potential involvement of PARN, CCR4/NOT, maskin, pumilio, Xp54 (Ddx6, Rck), other P-body components and isoforms of the cap binding initiation factor eIF4E. Finally we discuss some of the remaining questions regarding the mechanisms of translational regulation by cytoplasmic polyadenylation and give our view on where our knowledge is likely to be expanded in the near future.

1 July 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
YKYi Wen Kong
Yi Wen Kong
ICIan G. Cannell
Ian G. Cannell
CMCornelia de Moor
Cornelia de Moor
KHKirsti Hill
Kirsti Hill
PGPaul G. Garside
Paul G. Garside
MBMartin Bushell
Martin Bushell
MicroRNAs (miRNAs) are noncoding RNAs that base pair imperfectly to homologous regions in target mRNAs and negatively influence the synthesis of the corresponding proteins. Repression is mediated by a number of mechanisms, one of which is the direct inhibition of protein synthesis. Surprisingly, previous studies have suggested that two mutually exclusive mechanisms exist, one acting at the initiation phase of protein synthesis and the other at a postinitiation event. Here, we resolve this apparent dichotomy by demonstrating that the promoter used to transcribe the mRNA influences the type of miRNA-mediated translational repression. Transcripts derived from the SV40 promoter that contain let-7 target sites in their 3′ UTRs are repressed at the initiation stage of translation, whereas essentially identical mRNAs derived from the TK promoter are repressed at a postinitiation step. We also show that there is a miR-34 target site within the 3′ UTR of c- myc mRNA and that promoter dependency is also true for this endogenous 3′ UTR. Overall, these data establish a link between the nuclear history of an mRNA and the mechanism of miRNA-mediated translational regulation in the cytoplasm.

15 April 1999 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
CMCornelia de Moor
Cornelia de Moor
JRJoel D. Richter
Joel D. Richter
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 January 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YWYing Ying Wong
Ying Ying Wong
AMAlice Moon
Alice Moon
RDRuth Duffin
Ruth Duffin
ABAdeline Barthet-Barateig
Adeline Barthet-Barateig
HMHedda A. Meijer
Hedda A. Meijer
CMCornelia de Moor
Cornelia de Moor
3′-Deoxyadenosine, also known as cordycepin, is a known polyadenylation inhibitor with a large spectrum of biological activities, including anti-proliferative, pro-apoptotic and anti-inflammatory effects. In this study we confirm that cordycepin reduces the length of poly(A) tails, with some mRNAs being much more sensitive than others. The low doses of cordycepin that cause poly(A) changes also reduce the proliferation of NIH3T3 fibroblasts. At higher doses of the drug we observed inhibition of cell attachment and a reduction of focal adhesions. Furthermore, we observed a strong inhibition of total protein synthesis that correlates with an inhibition of mammalian target of rapamycin (mTOR) signaling, as observed by reductions in Akt kinase and 4E-binding protein (4EBP) phosphorylation. In 4EBP knock-out cells, the effect of cordycepin on translation is strongly reduced, confirming the role of this modification. In addition, the AMP-activated kinase (AMPK) was shown to be activated. Inhibition of AMPK prevented translation repression by cordycepin and abolished 4EBP1 dephosphorylation, indicating that the effect of cordycepin on mTOR signaling and protein synthesis is mediated by AMPK activation. We conclude that many of the reported biological effects of cordycepin are likely to be due to its effects on mTOR and AMPK signaling.